Guangzhou Magpie Pharmaceuticals Co., Ltd.
PrivateLast Round
Early Funding
Apr 20, 2020
Est. Valuation
$123.9M
Total Funding Raised
$28.88M
Company Overview
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a biotechnology company that develops innovative small molecule drugs for the treatment of cardiovascular, cerebrovascular, neurodegenerative, and mitochondrial dysfunction diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Comparables
Compare Guangzhou Magpie Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prilenia Therapeutics | 74% | |
| QurAlis | 74% | |
| Simcere Pharmaceutical Group | 74% |
Guangzhou Magpie Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 20, 2020 | ||||
| Series B | Feb 12, 2019 | ||||
| Series A Extension | Sep 1, 2017 | ||||
| Series A | Dec 1, 2016 |
Guangzhou Magpie Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series B |
| Guoqian Investment | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 271% MoM.
- Apr 20, 2020
$14.1M raised from Zhejiang CONBA Pharmaceutical Co Ltd.
Guangzhou Magpie Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou Magpie Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Magpie Pharmaceuticals Co., Ltd. a public or private company?
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Guangzhou Magpie Pharmaceuticals Co., Ltd.?
Guangzhou Magpie Pharmaceuticals Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Guangzhou Magpie Pharmaceuticals Co., Ltd. worth (valuation)?
Valuation information for Guangzhou Magpie Pharmaceuticals Co., Ltd. is not publicly available.
Can I buy Guangzhou Magpie Pharmaceuticals Co., Ltd. stock?
Guangzhou Magpie Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou Magpie Pharmaceuticals Co., Ltd.'s last funding round?
Funding round information for Guangzhou Magpie Pharmaceuticals Co., Ltd. is not publicly available.
Who are the main investors in Guangzhou Magpie Pharmaceuticals Co., Ltd.?
Investor information for Guangzhou Magpie Pharmaceuticals Co., Ltd. is not publicly disclosed.
Will Guangzhou Magpie Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Magpie Pharmaceuticals Co., Ltd..
How can I track Guangzhou Magpie Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Magpie Pharmaceuticals Co., Ltd.'s secondary market activity and sign up for updates.